Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025

Cleveland Clinic Heart Failure Summit Expanding the Frontiers of Contemporary Team Management 2025

Include: 7 videos + 38 pdfs, size: 2.21 GB

 Target Audience: cardiologists, internists, primary care physicians

 Information:

This course provides comprehensive training for healthcare professionals in the advanced management of heart failure. The curriculum is designed to equip participants with the latest knowledge and skills necessary to optimize patient outcomes through innovative therapeutic strategies and interventions.

After completing this course, participants will be able to

• Apply appropriate strategies to optimize use of current and novel drug therapy of heart failure with reduced left ventricular ejection fraction
• Describe how to utilize medical devices and surgical therapies in the care of heart failure patients
• Discuss the clinical profile of heart failure and differentiate between reduced and preserved ejection fraction patients
• Discuss the latest findings concerning pharmacological approaches to heart failure with midrange or preserved ejection fraction
• Employ current therapeutic strategies for cardiac amyloid and hypertrophic cardiomyopathy
• Identify options for electrophysiological interventions to address risk of sudden death and atrial arrhythmias in patients with heart failure

Who Should Attend?

The course is directed to physicians, physician assistants, pharmacists, nurse practitioners, nurses, and all healthcare providers with an interest in treating and managing patients with heart failure.

 Topics:

• Agenda.pdf
  June 6 Advanced evaluation of the breathless patient.pdf
  June 6 AF ablation and the pulsed field era.pdf
  June 6 Arrhythmogenic cardiomyopathies and genetic testing.pdf
  June 6 Breakthroughs in obesity-related HFpEF.pdf
  June 6 Cardiac contractility modulation.pdf
  June 6 Current and emerging device-based therapies for HFpEF.pdf
  June 6 Educating and engaging the patient of tomorrow.pdf
  June 6 GDMT optimization across the inpatient-outpatient domain.pdf
  June 6 Harnessing tech for GDMT optimization and readmission reduction.pdf
  June 6 Harnessing the heart team for GDMT equity.pdf
  June 6 HF STATS The changing face of heart failure.pdf
  June 6 Lessons learnt for diverse HF trial recruitment.pdf
  June 6 New insights into HFpEF mechanisms.pdf
  June 6 Novel therapies for cardiomyopathies.pdf
  June 6 Remote monitoring in the “AI era”- Leveraging new devices and algorithms.pdf
  June 6 Remote monitoring the “old school” way- Weights, vitals and symptoms.pdf
  June 6 Session 1 – Updates in HF Epidemiology and Population Health.mp4
  June 6 Session 2 – HFrEF and EP Innovations.mp4
  June 6 Session 3 – HFpEF and Pulmonary Hypertension.mp4
  June 6 Session 4A – Meet the Clinical Trialists (Concurrent Session).mp4
  June 6 The future of remote HF and EP monitoring.pdf
  June 6 The LAA and controversies in anticoagulation.pdf
  June 6 The next frontier- earlier diagnosis and treatment of HF.pdf
  June 6 The next generation HFrEF therapies.pdf
  June 6 Trials and tribulations in valvular interventions.pdf
  June 6 Ventricular tachycardia in patients with HFrEF.pdf
  June 6 What’s new in pulmonary hypertension.pdf
  June 7 A positive PET scan- What comes next.pdf
  June 7 Collapse to comeback- Improving outcomes after cardiac arrest.pdf
  June 7 DanGer ahead- Seeking an evidence base for shock management.pdf
  June 7 Evolutions in organ preservation and transportation.pdf
  June 7 Fixing the flow- Revascularization for the high-risk patient.pdf
  June 7 Getting shock right- Managing the right ventricle.pdf
  June 7 HCM in the era of myosin inhibition.pdf
  June 7 LVADs in a Transplant World.pdf
  June 7 Managing MCS at a non-transplant center.pdf
  June 7 Managing TTR cardiac amyloidosis in 2025.pdf
  June 7 Multidisciplinary cardiac care during pregnancy.pdf
  June 7 Post-heart transplant outcomes and management innovations.pdf
  June 7 Session 1 – Cardiomyopathies (amyloid, HCM, Sarcoid) and HFrEF.mp4
  June 7 Session 2 – MCS and TX.mp4
  June 7 Session 3 – Cardiogenic shock and critical care.mp4
  June 7 The next generation of LVADs and trials.pdf
  June 7 Transplant and VAD options in congenital conditions.pdf